BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amarnath Praphakar R, Sumathra M, Sam Ebenezer R, Vignesh S, Shakila H, Rajan M. Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration. Int J Pharm 2019;565:543-56. [PMID: 31102805 DOI: 10.1016/j.ijpharm.2019.05.035] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Balde A, Kim SK, Benjakul S, Nazeer RA. Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review. Int J Biol Macromol 2022;220:1464-79. [PMID: 36116588 DOI: 10.1016/j.ijbiomac.2022.09.116] [Reference Citation Analysis]
2 Seyhan SA, Alkaya DB, Cesur S, Oktar FN, Gunduz O. Preparation and characterization of pure natural hydroxyapatite derived from seashells for controlled drug delivery. J Aust Ceram Soc. [DOI: 10.1007/s41779-022-00739-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lavanya K, Swetha S, Selvamurugan N. Biopolymers/Ceramic-Based Nanocomposite Scaffolds for Drug Delivery in Bone Tissue Engineering. Polymeric and Natural Composites 2022. [DOI: 10.1007/978-3-030-70266-3_11] [Reference Citation Analysis]
4 Dalavi PA, Murugan SS, Anil S, Venkatesan J. Biological macromolecules in tissue engineering. Biological Macromolecules 2022. [DOI: 10.1016/b978-0-323-85759-8.00016-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hua L, Qian H, Lei T, Liu W, He X, Zhang Y, Lei P, Hu Y. Anti-tuberculosis drug delivery for tuberculous bone defects. Expert Opin Drug Deliv 2021. [PMID: 34758697 DOI: 10.1080/17425247.2021.2005576] [Reference Citation Analysis]
6 Miao J, Gao P, Li Q, He K, Zhang L, Wang J, Huang L. Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review. Int J Mol Sci 2021;22:11227. [PMID: 34681886 DOI: 10.3390/ijms222011227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shi P, Amarnath Praphakar R, Deepa S, Suganya K, Gupta P, Ullah R, Bari A, Murugan M, Rajan M. A promising drug delivery candidate (CS-g-PMDA-CYS-fused gold nanoparticles) for inhibition of multidrug-resistant uropathogenic Serratia marcescens. Drug Deliv 2020;27:1271-82. [PMID: 32885688 DOI: 10.1080/10717544.2020.1809557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Arjama M, Mehnath S, Rajan M, Jeyaraj M. Injectable cuttlefish HAP and macromolecular fibroin protein hydrogel for natural bone mimicking matrix for enhancement of osteoinduction progression. Reactive and Functional Polymers 2021;160:104841. [DOI: 10.1016/j.reactfunctpolym.2021.104841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
9 Shi J, Zhao H, Wu F, Gan X. Synthesis and characterization of an injectable rifampicin-loaded chitosan/hydroxyapatite bone cement for drug delivery. Journal of Materials Research 2021;36:487-498. [DOI: 10.1557/s43578-020-00027-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Azger Dustachkeer V, Nirmal CR, Rajadas SE, Saadhali SA, Kannayan S, Padmanaban VP. Nanotheranostic management of drug-resistant tuberculosis. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy 2021. [DOI: 10.1016/b978-0-12-819985-5.00004-8] [Reference Citation Analysis]
11 Pacheco-Quito EM, Ruiz-Caro R, Veiga MD. Carrageenan: Drug Delivery Systems and Other Biomedical Applications. Mar Drugs 2020;18:E583. [PMID: 33238488 DOI: 10.3390/md18110583] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 33.0] [Reference Citation Analysis]
12 Zomorodbakhsh S, Abbasian Y, Naghinejad M, Sheikhpour M. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis. Int J Nanomedicine 2020;15:5901-9. [PMID: 32884258 DOI: 10.2147/IJN.S251524] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
13 Rajan M, George Raj ICM, Rajendran AP. Biosynthesized Nanoparticles and Their Biological Applications. In: Krishnan A, Chuturgoon A, editors. Integrative Nanomedicine for New Therapies. Cham: Springer International Publishing; 2020. pp. 71-111. [DOI: 10.1007/978-3-030-36260-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sumathra M, Rajan M, Amarnath Praphakar R, Marraiki N, Elgorban AM. In Vivo Assessment of a Hydroxyapatite/κ-Carrageenan-Maleic Anhydride-Casein/Doxorubicin Composite-Coated Titanium Bone Implant. ACS Biomater Sci Eng 2020;6:1650-62. [PMID: 33455363 DOI: 10.1021/acsbiomaterials.9b01750] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
15 Vinothini K, Daisy EAC, Rajan M. Mechanism of loading and release in nanocontainers. Smart Nanocontainers 2020. [DOI: 10.1016/b978-0-12-816770-0.00005-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Jampílek J, Kráľová K. Nanoweapons Against Tuberculosis. Nanoformulations in Human Health 2020. [DOI: 10.1007/978-3-030-41858-8_21] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]